• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群与肥胖:从相关性到因果关系。

The gut microbiota and obesity: from correlation to causality.

机构信息

State Key Laboratory for Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University. Ministry of Education Key Laboratory for Systems Biomedicine, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, 800 Dongchuan Road, Minhang Campus, Shanghai 200240, China.

出版信息

Nat Rev Microbiol. 2013 Sep;11(9):639-47. doi: 10.1038/nrmicro3089. Epub 2013 Aug 5.

DOI:10.1038/nrmicro3089
PMID:23912213
Abstract

The gut microbiota has been linked with chronic diseases such as obesity in humans. However, the demonstration of causality between constituents of the microbiota and specific diseases remains an important challenge in the field. In this Opinion article, using Koch's postulates as a conceptual framework, I explore the chain of causation from alterations in the gut microbiota, particularly of the endotoxin-producing members, to the development of obesity in both rodents and humans. I then propose a strategy for identifying the causative agents of obesity in the human microbiota through a combination of microbiome-wide association studies, mechanistic analysis of host responses and the reproduction of diseases in gnotobiotic animals.

摘要

肠道微生物群与人类的肥胖等慢性疾病有关。然而,证明微生物群的组成成分与特定疾病之间存在因果关系仍然是该领域的一个重要挑战。在这篇观点文章中,我使用科赫假设作为概念框架,探讨了从肠道微生物群的改变,特别是内毒素产生菌的改变,到啮齿动物和人类肥胖发展的因果关系。然后,我通过宏基因组关联研究、宿主反应的机制分析以及无菌动物疾病的再现,提出了一种在人类微生物群中识别肥胖致病因子的策略。

相似文献

1
The gut microbiota and obesity: from correlation to causality.肠道微生物群与肥胖:从相关性到因果关系。
Nat Rev Microbiol. 2013 Sep;11(9):639-47. doi: 10.1038/nrmicro3089. Epub 2013 Aug 5.
2
Gut microbiota and obesity: lessons from the microbiome.肠道微生物群与肥胖:来自微生物组的启示。
Brief Funct Genomics. 2013 Jul;12(4):381-7. doi: 10.1093/bfgp/elt014. Epub 2013 Apr 24.
3
Emerging role of intestinal microbiota and microbial metabolites in metabolic control.肠道微生物群和微生物代谢产物在代谢控制中的新作用。
Diabetologia. 2017 Apr;60(4):613-617. doi: 10.1007/s00125-016-4192-0. Epub 2016 Dec 24.
4
The gut microbiota and its potential role in obesity.肠道微生物群及其在肥胖中的潜在作用。
Future Microbiol. 2018 Apr;13:589-603. doi: 10.2217/fmb-2017-0179. Epub 2018 Mar 13.
5
Gut microbiota and obesity: role in aetiology and potential therapeutic target.肠道微生物群与肥胖:在病因学中的作用及潜在治疗靶点
Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):585-97. doi: 10.1016/j.bpg.2014.07.005. Epub 2014 Jul 11.
6
Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease.肠道微生物群在肥胖、2型糖尿病和阿尔茨海默病中的作用。
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):305-11. doi: 10.2174/18715273113126660147.
7
The guts of obesity: progress and challenges in linking gut microbes to obesity.肥胖的内在机制:将肠道微生物与肥胖联系起来的进展与挑战
Discov Med. 2015 Feb;19(103):81-8.
8
Assessing the human gut microbiota in metabolic diseases.评估代谢疾病中的人类肠道微生物群。
Diabetes. 2013 Oct;62(10):3341-9. doi: 10.2337/db13-0844.
9
Gut Microbiome and Obesity. How to Prove Causality?肠道微生物组与肥胖。如何证明因果关系?
Ann Am Thorac Soc. 2017 Nov;14(Supplement_5):S354-S356. doi: 10.1513/AnnalsATS.201702-117AW.
10
Diet, gut microbiota and cognition.饮食、肠道微生物群与认知
Metab Brain Dis. 2017 Feb;32(1):1-17. doi: 10.1007/s11011-016-9917-8. Epub 2016 Oct 5.

引用本文的文献

1
Preparation, structure, and biological activity of sulfated polysaccharides from green algae in the Cladophoraceae (Cladophorales, Ulvophyceae).来自绿藻纲(绿藻目,石莼纲)石莼科绿藻的硫酸化多糖的制备、结构及生物活性
Antonie Van Leeuwenhoek. 2025 Aug 15;118(9):131. doi: 10.1007/s10482-025-02146-0.
2
Potential Shifts in the Oral Microbiome Induced by Bariatric Surgery-A Scoping Review.减肥手术引起的口腔微生物群潜在变化——一项综述
Antibiotics (Basel). 2025 Jul 10;14(7):695. doi: 10.3390/antibiotics14070695.
3
Structure analysis of human gut microbiota associated with single-celled gut protists using Next-Generation Sequencing of 16S and 18S rRNA genes.

本文引用的文献

1
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity.阿克曼氏菌与肠道上皮细胞的串扰控制饮食诱导的肥胖。
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9066-71. doi: 10.1073/pnas.1219451110. Epub 2013 May 13.
2
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.肠道微生物群通过降低天然 FXR 拮抗剂牛磺-β-熊去氧胆酸的水平来调节胆汁酸代谢。
Cell Metab. 2013 Feb 5;17(2):225-35. doi: 10.1016/j.cmet.2013.01.003.
3
Host-derived nitrate boosts growth of E. coli in the inflamed gut.
利用16S和18S rRNA基因的新一代测序技术对与单细胞肠道原生生物相关的人类肠道微生物群进行结构分析。
Comput Struct Biotechnol J. 2025 Jun 6;27:2955-2967. doi: 10.1016/j.csbj.2025.06.006. eCollection 2025.
4
The role of probiotics in adolescents' obesity.益生菌在青少年肥胖中的作用。
Front Cell Infect Microbiol. 2025 Jul 2;15:1546627. doi: 10.3389/fcimb.2025.1546627. eCollection 2025.
5
Microbiome and metabolic disorder in prolactinoma: intrinsic gender differences and extrinsic therapy effects.泌乳素瘤中的微生物群与代谢紊乱:内在性别差异及外在治疗效果
Pituitary. 2025 Jul 3;28(4):83. doi: 10.1007/s11102-025-01544-x.
6
Alginate Oligosaccharide and Gut Microbiota: Exploring the Key to Health.海藻寡糖与肠道微生物群:探索健康的关键
Nutrients. 2025 Jun 11;17(12):1977. doi: 10.3390/nu17121977.
7
Microbiota in Gut-Heart Axis: Metabolites and Mechanisms in Cardiovascular Disease.肠道-心脏轴中的微生物群:心血管疾病中的代谢产物和机制
Compr Physiol. 2025 Jun;15(3):e70024. doi: 10.1002/cph4.70024.
8
Potential Therapeutic Targets for Androgenetic Alopecia (AGA) in Obese Individuals as Revealed by a Gut Microbiome Analysis: A Mendelian Randomization Study.肠道微生物组分析揭示的肥胖个体雄激素性脱发(AGA)的潜在治疗靶点:一项孟德尔随机化研究
Nutrients. 2025 May 31;17(11):1892. doi: 10.3390/nu17111892.
9
Gut Microbiota and COVID-19: Unraveling the Gut-Lung Axis and Immunomodulatory Therapies.肠道微生物群与2019冠状病毒病:揭示肠-肺轴与免疫调节疗法
ACS Infect Dis. 2025 Jul 11;11(7):1844-1853. doi: 10.1021/acsinfecdis.5c00250. Epub 2025 Jun 5.
10
Racial and Ethnic Disparities in NAFLD: Harnessing Epigenetic and Gut Microbiota Pathways for Targeted Therapeutic Approaches.非酒精性脂肪性肝病中的种族和民族差异:利用表观遗传学和肠道微生物群途径制定靶向治疗方法。
Biomolecules. 2025 May 5;15(5):669. doi: 10.3390/biom15050669.
宿主来源的硝酸盐可促进肠道炎症中的大肠杆菌生长。
Science. 2013 Feb 8;339(6120):708-11. doi: 10.1126/science.1232467.
4
The genetics of human obesity.人类肥胖的遗传学
Ann N Y Acad Sci. 2013 Apr;1281(1):178-90. doi: 10.1111/nyas.12020. Epub 2013 Jan 29.
5
Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice.遗传控制肥胖和肠道微生物组成对高脂肪、高蔗糖饮食的响应在小鼠中。
Cell Metab. 2013 Jan 8;17(1):141-52. doi: 10.1016/j.cmet.2012.12.007.
6
Pathophysiology of human visceral obesity: an update.人类内脏肥胖的病理生理学:更新。
Physiol Rev. 2013 Jan;93(1):359-404. doi: 10.1152/physrev.00033.2011.
7
An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice.从肥胖症人类肠道中分离出的机会性病原体可导致无菌小鼠肥胖。
ISME J. 2013 Apr;7(4):880-4. doi: 10.1038/ismej.2012.153. Epub 2012 Dec 13.
8
The gut microbiota, obesity and insulin resistance.肠道微生物群、肥胖和胰岛素抵抗。
Mol Aspects Med. 2013 Feb;34(1):39-58. doi: 10.1016/j.mam.2012.11.001. Epub 2012 Nov 16.
9
Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice.具有益生元作用的小麦衍生阿拉伯木聚糖低聚糖可增加饱腹相关肠道肽并降低饮食诱导肥胖小鼠的代谢内毒素血症。
Nutr Diabetes. 2012 Jan 23;2(1):e28. doi: 10.1038/nutd.2011.24.
10
A metagenome-wide association study of gut microbiota in type 2 diabetes.2 型糖尿病患者肠道微生物组的宏基因组关联研究。
Nature. 2012 Oct 4;490(7418):55-60. doi: 10.1038/nature11450. Epub 2012 Sep 26.